DEA issues first federal licenses to medical marijuana shops
More than 900 dispensaries across seven states received registrations Friday, a move that allows these businesses to finally deduct standard operating costs from their federal tax bills.
By Samantha Reed ·
The federal government has officially recognized a network of state-licensed medical marijuana dispensaries for the first time. The U.S. Drug Enforcement Administration issued initial registrations to over 900 businesses on Friday, marking a major administrative shift in how Washington, D.C. oversees the industry.
The Department of Justice confirmed the approvals cover licensed shops in Alabama, Florida, Mississippi, South Dakota, Texas, Virginia, and West Virginia. While the department did not release a specific list of the approved companies, the move signals the start of a formal federal relationship with the medical cannabis sector.
Attorney General Todd Blanche framed the action as a consumer protection measure. He stated that regulating the distribution of medical cannabis would help ensure broader access to chronic pain treatment while maintaining public safety.
This registration process follows an order signed by Blanche in April that moved state-licensed medical marijuana from Schedule I to Schedule III. The reclassification placed medical cannabis in the same category as drugs like codeine, which have established medical uses and a lower potential for abuse. This change legitimized the programs in the 40 states that have adopted them and created a streamlined path for producers, manufacturers, and distributors to register with the DEA.
The most immediate financial impact of these registrations involves federal taxes. Previously, because cannabis was classified as a federally illegal Schedule I substance, these businesses could not deduct normal operating expenses such as rent, advertising, or labor costs from their federal returns. Industry leaders described this limitation as financially damaging. With Schedule III status, those deductions are now expected to be allowed, reducing the tax burden on thousands of operators.
The DEA published a list showing that nearly 7,000 other cannabis businesses nationwide have applied for similar registration. Steph Sherer, founder of Americans for Safe Access, called the initial batch of licenses a tremendous victory for patient access. She noted the timing, pointing out that the approvals came just days before the 30th anniversary of California becoming the first state to legalize medical marijuana.
Uncertainties remain regarding how the DEA will regulate these newly registered entities. Some industry attorneys point out that state regulators often allow operators with certain criminal histories to run licensed businesses, whereas federal rules for Schedule III drugs may be stricter. It is also unclear how the agency will handle companies that serve both medical and recreational customers, a common practice in many states where the two markets have merged. Chris Lindsey, vice president of policy at the American Trade Association for Cannabis and Hemp, said stakeholders are watching to see what specific operational requirements the agency will impose on these businesses moving forward.
Currently, 24 states plus Washington, D.C. allow adult recreational use, while 40 states have medical systems. Only Idaho and Kansas ban marijuana entirely. The DEA requires registrants to pass pre-registration investigations and maintain strict controls over inventory, security, and recordkeeping.
Source: Bangor Daily News
